Skip to content
Tutorials Center
My learning

Topics

Lesson 17 of 48 ยท Pharmacodynamics and Dose-Response

Chapter 4 overview: pharmacodynamics and dose-response

Preview chapter 4: how concentration becomes effect, the dose-response curve, potency, efficacy, safety margins, variability and interactions, with a staircase picture and a PK-to-PD simulation.

Pharmacokinetics tells you how much drug is at the target. Pharmacodynamics (PD) tells you what that drug does there. The two fit together like the two halves of a bridge: PK carries the dose to a concentration, PD turns the concentration into an effect. Chapter 4 completes the toolkit by describing the relationship between dose or concentration and effect, comparing drugs, measuring safety, and explaining why different people respond differently.

Five rising steps from dose to concentration to receptor occupancy to cell response to clinical effect, with brackets marking pharmacokinetics and pharmacodynamics
From dose to clinical effect: the first two steps are pharmacokinetics, the last three pharmacodynamics.

What you will learn

  • The chain from dose to clinical effect, and which parts are PK and which PD.
  • What each lesson in this chapter covers.
  • How a concentration curve over time becomes an effect curve over time.

Key terms

  • Dose-response relationship: how the size of an effect depends on the dose or concentration.
  • Emax: the maximum effect a drug can produce.
  • EC50: the concentration that gives half of the maximum effect.
  • Therapeutic window: the range of concentration or dose that gives benefit with acceptable harm.
  • Variability: differences between individuals in dose needed or response seen.

The chain from dose to effect

Look at the staircase. Each step depends on the one before it, and a change at any step changes the result.

  1. Dose is what you give. It is under the control of the prescriber.
  2. Concentration at the target is set by PK: absorption, distribution, metabolism and excretion (Chapter 3).
  3. Receptor occupancy follows the binding law of Chapter 2: occupancy = [L] / ([L] + Kd).
  4. Cell and tissue response follows from occupancy, amplified or damped by the cell's signalling machinery.
  5. Clinical effect is what the patient notices or what a test measures: a lower blood pressure, relief from pain, a lower blood sugar.

Because the steps are chained, you can often reason about a surprising result by finding the step where something differs. A patient who has little response to a normal dose may have low concentration (a PK cause, such as fast metabolism), low occupancy (a binding cause), a weak cell response (a PD cause, such as down-regulated receptors) or a disease that overrides the drug.

What chapter 4 adds

Dose-response Shape of the curve
Compare drugs Potency and efficacy
Safety margins Therapeutic index
People differ Genes and disease

Four ideas turn kinetics into good prescribing.

1 / 2

What is in this chapter

  1. Dose-response curves explains graded and quantal curves, the Emax and Hill equations, why we plot on log axes, and how to fit EC50 from data.
  2. Potency, efficacy and safety separates potency from efficacy, and introduces the therapeutic index, margins of safety and the therapeutic window.
  3. Variability and pharmacogenomics covers why responses differ: age, disease, tolerance, placebo effects and genes such as CYP2D6.
  4. Drug interactions shows how drugs change each other's kinetics and effects, and how to think about additive, synergistic and antagonistic combinations.
  5. Chapter 4 review gathers the formulas and gives a longer quiz.

From a concentration curve to an effect curve

The simplest PD model is the Emax model: E = Emax ร— C / (EC50 + C). Plug in the concentration of the PK model at each moment and you obtain an effect-time curve. The simulation below does exactly that with made-up numbers. Notice two things. The effect curve is flatter on top than the concentration curve, because the Emax model saturates, and the duration of effect (time with effect above, say, 50%) depends on the concentration staying above the EC50.

Python Concentration and effect over time

Press Run (or Ctrl + Enter) to see the result here.

Program input ยท what you'd type while the program runs

Type the answers before you press Run, one per line. Each time the program reads a line (with input()), it gets the next line from this box.

Common misconceptions

  • "Effect is proportional to dose." Effect follows a saturating curve, so doubling the dose rarely doubles the effect.
  • "Plasma concentration is the effect." There may be a delay between concentration and effect, and the relationship is curved, not linear.

Check your understanding

Quick check ยท 3 questions

of 3 answered You scored / 3 ยท perfect!

  1. 1. Which step in the staircase is a pharmacokinetic step?

    The concentration reaching the target is set by absorption, distribution, metabolism and excretion.
  2. 2. In the Emax model, what is the effect when C = EC50?

    E = Emax x EC50 / (EC50 + EC50) = Emax / 2.
  3. 3. A patient has little response to a normal dose. Which could explain it?

    Both PK causes (low concentration) and PD causes (weak response) are possible.

Summary

  • The chain is dose, concentration, occupancy, cell response, clinical effect; the first two steps are PK, the rest PD.
  • The Emax model turns a concentration curve into an effect curve: E = Emax x C / (EC50 + C).
  • Chapter 4 covers dose-response curves, potency and efficacy, safety, variability and interactions.

Next: Dose-response curves